Page last updated: 2024-08-24

oseltamivir and Blood Clot

oseltamivir has been researched along with Blood Clot in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Anedda, L; Bianchini, L; Cuzzolin, L; Fanos, V; Finco, G; Marcialis, MA	1
Abdel-Rahman, SM; Wagner, J	1

Reviews

2 review(s) available for oseltamivir and Blood Clot

Article	Year
What if COVID-19 affects the child: which weapons and how to use them. European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:8 Topics: Adenosine Monophosphate; Adolescent; Age Factors; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Carrier State; Child; Child, Preschool; Chloroquine; Continuous Renal Replacement Therapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Extracorporeal Membrane Oxygenation; Glucocorticoids; Humans; Hydroxychloroquine; Immunization, Passive; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Infant, Newborn; Interferon-alpha; Lopinavir; Oseltamivir; Receptors, Cell Surface; Respiration, Artificial; Ribavirin; Ritonavir; SARS-CoV-2; Severity of Illness Index; Thrombosis	2021
Oseltamivir-warfarin interaction in hypoplastic left heart syndrome: case report and review. Pediatrics, 2015, Volume: 135, Issue:5 Topics: Anticoagulants; Antiviral Agents; Child; Drug Interactions; Humans; Hypoplastic Left Heart Syndrome; Influenza, Human; International Normalized Ratio; Male; Oseltamivir; Thrombosis; Warfarin	2015

Article

Year

What if COVID-19 affects the child: which weapons and how to use them.

European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:8

Topics: Adenosine Monophosphate; Adolescent; Age Factors; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Carrier State; Child; Child, Preschool; Chloroquine; Continuous Renal Replacement Therapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Extracorporeal Membrane Oxygenation; Glucocorticoids; Humans; Hydroxychloroquine; Immunization, Passive; Immunoglobulins, Intravenous; Immunologic Factors; Infant; Infant, Newborn; Interferon-alpha; Lopinavir; Oseltamivir; Receptors, Cell Surface; Respiration, Artificial; Ribavirin; Ritonavir; SARS-CoV-2; Severity of Illness Index; Thrombosis

2021

Oseltamivir-warfarin interaction in hypoplastic left heart syndrome: case report and review.

Pediatrics, 2015, Volume: 135, Issue:5

Topics: Anticoagulants; Antiviral Agents; Child; Drug Interactions; Humans; Hypoplastic Left Heart Syndrome; Influenza, Human; International Normalized Ratio; Male; Oseltamivir; Thrombosis; Warfarin

2015